The funding was led by the Development Bank of Wales to support the commercial launch of the Podium device.
"Detecting diabetic foot complications as early as possible is crucial as people with diabetes could suffer from a loss of feeling in their feet, which can lead to foot ulcers which increases the risk of amputation. Once a patient has received an amputation, their quality of life is impacted. More worryingly, life expectancy is 5 years post-amputation, on average."
The Port Talbot based customer experience firm secured backing from new and existing investors to grow its footprint in the Americas.
"We are delighted that the Development Bank of Wales remain supporters of Vizolution and continue to believe in what we do. Their investment, help and guidance over the years has meant a lot and has been a big part of our success. We look forward to many more successful years of working together."
The funding round was led by the Development Bank of Wales with participation from angel investors.
"We want to “Power Up” employees so that they feel confident in the workplace, no matter where they sit. With this new focus and investment, we felt the time was right to re-brand the platform. This latest round of funding will help us to accelerate the growth of the brand and work towards our goal of becoming the Netflix of career development. We are hugely proud of the success that Careercake has had to date and thrilled with the support we have had from the Development Bank of Wales and our investors."
The funding will support the construction of the company's first commercial facility in Barry.
"We are constantly striving to find exciting businesses in new markets. LIGNIA is a great example of this, as a product with a clear technical advantage for which there is already high demand."
The funding round was led by Newable Private Investing, the Development Bank of Wales, and angel investors.
"Jellyfish represent a source of ‘next generation’ collagen with diverse application potential, including for research in the medical, biotech and pharmaceutical markets,"